avasimibe has been researched along with Disease Exacerbation in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Johnson, B; Lubet, RA; Palen, K; Pan, J; Qiao, L; Sei, S; Shoemaker, RH; Wang, L; Wang, Y; You, M; Zhang, Q | 1 |
| Anderson, T; Blue, JW; Grégoire, J; Heinonen, T; Imus, J; L'Allier, PL; Lambert, J; Lespérance, J; Rodés, J; Tardif, JC | 1 |
| Cohen, E; Grégoire, J; Guertin, MC; Heinonen, T; Ibrahim, R; Keller, PF; L'Allier, PL; Lavoie, MA; LeMay, M; Levesque, S; Tardif, JC | 1 |
| Berry, C; Grégoire, J; Ibrahim, R; L'Allier, PL; Lespérance, J; Levesque, S; Tardif, JC | 1 |
| Badimon, JJ; Chew, DP; Corti, R; Fallon, JT; Fayad, ZA; Fuster, V; Helft, G; Worthley, MI; Worthley, SG; Zaman, AG | 1 |
| Krause, BR; Nicolosi, RJ; Wilson, TA | 1 |
1 trial(s) available for avasimibe and Disease Exacerbation
| Article | Year |
|---|---|
Design features of the Avasimibe and Progression of coronary Lesions assessed by intravascular UltraSound (A-PLUS) clinical trial.
Topics: Acetamides; Acetates; Adult; Coronary Angiography; Coronary Artery Disease; Disease Progression; Double-Blind Method; Female; Humans; Hypolipidemic Agents; Male; Research Design; Statistics as Topic; Sulfonamides; Sulfonic Acids; Ultrasonography | 2002 |
5 other study(ies) available for avasimibe and Disease Exacerbation
| Article | Year |
|---|---|
Potentiation of Kras peptide cancer vaccine by avasimibe, a cholesterol modulator.
Topics: Acetamides; Acetates; Amino Acid Sequence; Animals; Cancer Vaccines; Cholesterol; Disease Progression; Lung Neoplasms; Mice; Proto-Oncogene Proteins p21(ras); Sulfonamides; Sulfonic Acids; T-Lymphocytes, Regulatory; Vaccines, Subunit | 2019 |
Effect of atherosclerotic regression on total luminal size of coronary arteries as determined by intravascular ultrasound.
Topics: Acetamides; Acetates; Cholesterol, LDL; Coronary Artery Disease; Coronary Vessels; Disease Progression; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Image Processing, Computer-Assisted; Male; Middle Aged; Regression Analysis; Sulfonamides; Sulfonic Acids; Total Lung Capacity; Ultrasonography, Interventional | 2006 |
Comparison of intravascular ultrasound and quantitative coronary angiography for the assessment of coronary artery disease progression.
Topics: Acetamides; Acetates; Aged; Atherosclerosis; Biomarkers; Cineangiography; Coronary Angiography; Coronary Artery Disease; Disease Progression; Drug Therapy, Combination; Dyslipidemias; Endothelium, Vascular; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Image Processing, Computer-Assisted; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Randomized Controlled Trials as Topic; Sterol O-Acyltransferase; Sulfonamides; Sulfonic Acids; Ultrasonography, Interventional | 2007 |
Statin therapy alone and in combination with an acyl-CoA:cholesterol O-acyltransferase inhibitor on experimental atherosclerosis.
Topics: Acetamides; Acetates; Animals; Aorta, Abdominal; Aortic Diseases; Atherosclerosis; Atorvastatin; Catheterization; Cholesterol; Disease Progression; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Magnetic Resonance Imaging; Matrix Metalloproteinase 1; Matrix Metalloproteinase 3; Pyrroles; Rabbits; Random Allocation; Sterol O-Acyltransferase; Sulfonamides; Sulfonic Acids | 2007 |
The ACAT inhibitor, CI-1011 is effective in the prevention and regression of aortic fatty streak area in hamsters.
Topics: Acetamides; Acetates; Animals; Aorta; Arteriosclerosis; Cholesterol; Cholesterol Esters; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Cricetinae; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Enzyme Inhibitors; Liver; Male; Reference Values; Sterol O-Acyltransferase; Sulfonamides; Sulfonic Acids; Time Factors; Triglycerides | 1998 |